Clinical & Pharma

Innorna's mRNA Therapy for Wilson's Disease Gains FDA Boost
Clinical & Pharma Innorna's mRNA Therapy for Wilson's Disease Gains FDA Boost

Innorna, a biotechnology firm from China, has made significant strides in developing an mRNA therapeutic called IN013, designed specifically for Wilson's disease. This progressive step has been further empowered by the US Food and Drug Administration (FDA), which has conferred rare pediatric

Rotavirus Vaccine Alters Diarrheal Virus Trends in Kenyan Children
Clinical & Pharma Rotavirus Vaccine Alters Diarrheal Virus Trends in Kenyan Children

The escalating battle against acute gastroenteritis (AGE) in young Kenyan children has witnessed a transformative development since the introduction of the rotavirus vaccine into Kenya’s National Immunization Program in 2014. This intervention marked a substantial milestone in combating rotavirus, h

Mentorship and Research Excellence in Public Health
Clinical & Pharma Mentorship and Research Excellence in Public Health

In the realm of public health, the impact of effective mentorship, exemplified by Archana McEligot, a prominent professor at Cal State Fullerton, demonstrates how significant expertise in fields like epidemiology, nutrition, and cancer research can be. Over her distinguished three-decade career,

Is Targeted Protein Degradation the Future of Medicine?
Clinical & Pharma Is Targeted Protein Degradation the Future of Medicine?

Targeted Protein Degradation (TPD) is ushering in a transformative era in medicine by offering innovative therapeutic strategies that focus on eliminating disease-causing proteins. Unlike traditional therapies that aim to inhibit protein activity, TPD proposes the removal of harmful proteins, which

Germany's EKFS Launches €10M Grants for US Medical Researchers
Clinical & Pharma Germany's EKFS Launches €10M Grants for US Medical Researchers

The Else Kröner-Fresenius Foundation (EKFS) has unveiled its groundbreaking 'Else Kröner Excellence Grants 2025' initiative, designed to attract leading medical researchers from the United States to Germany. This ambitious program is backed by a substantial budget of 10 million euros for 2

Rising Costs and US Tariffs Strain Malaysian GP Clinics
Clinical & Pharma Rising Costs and US Tariffs Strain Malaysian GP Clinics

Private general practitioner (GP) clinics in Malaysia are grappling with intense financial pressures exacerbated by rising costs and global trade instability. Significant among these challenges is the looming potential expansion of US tariffs to pharmaceuticals. This situation poses severe

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later